RT Journal Article
SR Electronic
T1 A control approach to the Covid-19 disease using a SEIHRD dynamical model
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.27.20115295
DO 10.1101/2020.05.27.20115295
A1 Pazos, Fernando
A1 Felicioni, Flavia E.
YR 2020
UL http://medrxiv.org/content/early/2020/05/30/2020.05.27.20115295.abstract
AB The recent worldwide epidemic of Covid-19 disease, for which there is no vaccine or medications to prevent or cure it, led to the adoption of public health measures by governments and populations in most of the affected countries to avoid the contagion and its spread. These measures are known as nonpharmaceutical interventions (NPIs) and their implementation clearly produces social unrest as well as greatly affects the economy. Frequently, NPIs are implemented with an intensity quantified in an ad hoc manner. Control theory offers a worth-while tool for determining the optimal intensity of the NPIs in order to avoid the collapse of the healthcare system while keeping them as low as possible, yielding in a policymakers concrete guidance. We propose here the use of a simple proportional controller that is robust to large parametric uncertainties in the model used.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding has been received to suport this researchAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:there is no IRB/oversight aproval or exemptionAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesall the data used in the article are available in https://www.worldometers.info/coronavirus/ https://www.worldometers.info/coronavirus/